NORGES BANK - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$75,753,000
+44.3%
440,168
+5.2%
0.02%
+54.5%
Q2 2021$52,498,000
-8.9%
418,348
-1.6%
0.01%
-15.4%
Q1 2021$57,637,000
-5.7%
425,023
-11.0%
0.01%
-7.1%
Q4 2020$61,111,000
+13.7%
477,6550.0%0.01%0.0%
Q3 2020$53,751,000
+22.0%
477,655
+3.3%
0.01%
+7.7%
Q2 2020$44,059,000
-10.9%
462,466
-16.0%
0.01%
-27.8%
Q1 2020$49,449,000
+69.5%
550,2280.0%0.02%
+125.0%
Q4 2019$29,173,000
+37.8%
550,228
+2.7%
0.01%
+33.3%
Q3 2019$21,174,000
+4.0%
535,905
+8.1%
0.01%0.0%
Q2 2019$20,361,000
-6.9%
495,645
+5.6%
0.01%
-14.3%
Q1 2019$21,859,000
+24.7%
469,364
+16.6%
0.01%0.0%
Q4 2018$17,535,000
-23.9%
402,6520.0%0.01%0.0%
Q3 2018$23,044,000
+18.0%
402,6520.0%0.01%0.0%
Q2 2018$19,537,000
+24.1%
402,6520.0%0.01%
+16.7%
Q1 2018$15,744,000
-7.9%
402,6520.0%0.01%0.0%
Q4 2017$17,089,000
+13.7%
402,6520.0%0.01%0.0%
Q3 2017$15,027,000
+53.3%
402,652
+24.8%
0.01%
+50.0%
Q2 2017$9,805,000
+14.8%
322,6520.0%0.00%0.0%
Q1 2017$8,541,000
+3.7%
322,6520.0%0.00%0.0%
Q4 2016$8,234,000
-26.2%
322,6520.0%0.00%
-20.0%
Q3 2016$11,153,000
+72.8%
322,652
+69.9%
0.01%
+66.7%
Q2 2016$6,453,000
+602.9%
189,916
+445.7%
0.00%
Q1 2016$918,000
-37.3%
34,800
+16.0%
0.00%
-100.0%
Q4 2015$1,463,000
+95.9%
30,0000.0%0.00%
Q3 2015$747,00030,0000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders